Article

(2012) Impact of erythropoietin on sustained virological response to peginterferon and ribavirin therapy for HCV infection: a systematic review and meta-analysis. Journal of Viral Hepatitis. pp. 88-93. ISSN 1352-0504

(2012) Low Dose Ribavirin for Treatment of Hepatitis C Virus Infected Thalassemia Major Patients; New Indications for Combination Therapy. Hepatitis Monthly. pp. 372-381. ISSN 1735-143X

(2012) Renal grafts from anti-hepatitis B core-positive donors: a quantitative review of the literature. Transplant Infectious Disease. pp. 445-451. ISSN 1398-2273

(2012) Seroepidemiology of HBV Infection in Kermanshah- West of Iran; A Population Based Study. Jundishapur Journal of Microbiology. pp. 564-569. ISSN 2008-3645

(2012) Seroepidemiology of HBV Infection in South-East of Iran; A Population Based Study. Iranian Red Crescent Medical Journal. pp. 283-288. ISSN 2074-1804

(2012) Seroprevalence of HBV infection and its risk factors in the west of iran: A population-based study. International Journal of Preventive Medicine. pp. 770-775. ISSN 20087802 (ISSN)

(2012) Seroprevalence of Hepatitis B Virus Infection and Its Risk Factors in the West of Iran: A Population-based Study. Int J Prev Med. pp. 770-5. ISSN 2008-7802

(2012) Standard and pegylated interferon therapy of HDV infection: A systematic review and meta-analysis. Journal of Research in Medical Sciences. pp. 967-974. ISSN 1735-1995

(2011) Effect of cesarean section on the risk of perinatal transmission of hepatitis C virus from HCV-RNA+/HIV- mothers: a meta-analysis. Archives of Gynecology and Obstetrics. pp. 255-260. ISSN 0932-0067

(2011) Effect of oral levamisole on immunological response to hepatitis B vaccine in haemodialysis patients. Alimentary Pharmacology & Therapeutics. p. 160. ISSN 0269-2813

(2011) Epidemiology and risk factors of HCV infection among hemodialysis patients in countries of the Eastern Mediterranean Regional Office of WHO (EMRO): A quantitative review of literature. Journal of Public Health. pp. 191-203. ISSN 09431853 (ISSN)

(2011) Epidemiology of HCV Infection among Thalassemia Patients in Eastern Mediterranean Countries: Some Comments Reply. Iranian Red Crescent Medical Journal. p. 145. ISSN 2074-1804

(2011) Lipid Profiles and Hepatitis C Viral Markers in HCV-Infected Thalassemic Patients. Gut and Liver. pp. 348-355. ISSN 1976-2283

(2011) OPTIMAL DURATION OF ANTI-HCV THERAPY IN GENOTYPE-1 SLOW RESPONDERS WITH HIGH VIRAL LOAD; A SYSTEMATIC REVIEW AND META-ANALYSIS. Journal of Hepatology. S196-S196. ISSN 0168-8278

(2011) Optimal Duration of Treatment for HCV Genotype 1 Infection in Slow Responders: A Meta-Analysis. Hepatitis Monthly. pp. 612-619. ISSN 1735-143X

(2011) Reply to Dr Kabir comments. Iranian Red Crescent Medical Journal. p. 145. ISSN 20741804 (ISSN)

(2010) The Comparative Efficacy and Safety of Peginterferon Alpha-2a vs. 2b for the Treatment of Chronic HCV Infection: A Meta-Analysis. Hepatitis Monthly. pp. 121-131. ISSN 1735-143X

(2010) Comparative efficacy and overall safety of different doses of consensus interferon for treatment of chronic HCV infection: a systematic review and meta-analysis. European Journal of Clinical Pharmacology. pp. 1071-1079. ISSN 0031-6970

(2010) Distribution of Hepatitis C Virus Genotypes in Iranian Patients with Congenital Bleeding Disorders. Iranian Red Crescent Medical Journal. pp. 608-614. ISSN 2074-1804

(2010) Effects of Oral Levamisole as an Adjuvant to Hepatitis B Vaccine in Adults With End-Stage Renal Disease: A Meta-Analysis of Controlled Clinical Trials. Clinical Therapeutics. pp. 1-10. ISSN 0149-2918

(2010) Epidemiology of HCV Infection among Thalassemia Patients in Eastern Mediterranean Countries: a Quantitative Review of Literature. Iranian Red Crescent Medical Journal. pp. 365-376. ISSN 2074-1804

(2010) Erythropoietin adjuvant therapy and sustained virological response in HCV-infected patients. Alimentary Pharmacology & Therapeutics. pp. 509-510. ISSN 0269-2813

(2010) IMMUNOLOGICAL RESPONSE TO HEPATITIS B VACCINE IN POLYTRANSFUSED THALASSEMIC PATIENTS. Pediatric Hematology and Oncology. pp. 324-325. ISSN 0888-0018

(2010) Knowledge, Attitudes and Practice of Iranian Medical Specialists regarding Hepatitis B and C. Hepatitis Monthly. pp. 176-182. ISSN 1735-143X

(2010) Meta-Analysis of Factors Associated With Sustained Viral Response in Patients on Hemodialysis Treated With Standard or Pegylated Interferon for Hepatitis C Infection. Iranian Journal of Kidney Diseases. pp. 181-194. ISSN 1735-8582

(2010) Peginterferon α-2a and ribavirin treatment of patientswith haemophilia and hepatitis C virus infection: A single-centre study of 367 cases. Liver International. pp. 1173-1180. ISSN 14783223 (ISSN)

(2010) SAFETY AND EFFICACY OF RIBAVIRIN FOR TREATMENT OF THALASSEMIC PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION; A CONTROLLED CLINICAL TRIAL OF 280 CASES. Journal of Hepatology. S28-S28. ISSN 0168-8278

(2010) Therapy of hepatitis C in thalassemia: the influence of iron on achieving sustained viral response. Annals of Hematology. pp. 215-216. ISSN 0939-5555

(2010) Treatment of chronic hepatitis C in polytransfused thalassaemic patients: a meta-analysis. Journal of Viral Hepatitis. pp. 236-244. ISSN 1352-0504

(2010) The effect of diabetes mellitus on immunological response to hepatitis B virus vaccine in individuals with chronic kidney disease: A meta-analysis of current literature. Vaccine. pp. 3773-3777. ISSN 0264-410X

(2009) Distribution of hepatitis C virus genotype in Iranian multiply transfused patients with thalassemia. Transfusion. pp. 2195-2199. ISSN 0041-1132

(2009) Outcome of combination antiviral therapy in hepatitis C virus infected patients with sickle cell disease. Saudi Medical Journal. p. 1107. ISSN 0379-5284

(2009) RE: Serum viral markers in Iranian patients with congenital bleeding disorder. Annals of Saudi Medicine. p. 322. ISSN 0256-4947